EGFR and lung carcinoma: Song et al.73 demonstrated that dasatinib exerted growth inhibitory activity in apoptosis in gefitinib-sensitive EGFR mutant lung cancer cells in vitro via down-regulation of activated survival proteins, namely Akt and STAT3.